DRAXIS Health Appoints New York Investor Relations Firm.Business Editors MISSISSAUGA, Ontario--(BUSINESS WIRE)--Aug. 17, 2001 DRAXIS Health Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :DRAX)(TSE See Tokyo Stock Exchange. TSE 1. See Tokyo Stock Exchange (TSE). 2. See Toronto Stock Exchange (TSE). :DAX.) has engaged The Investor Relations Investor relations The process by which the corporation communicates with its investors. Group, Inc. ("IRG (1) (InterRecord Gap) See interrecord gap. (2) (Internet Research Group, Los Altos, CA, www.irgintl.com) A research and consulting firm founded in 1993 that specializes in developing business strategies for Internet-related companies. "), based in New York City New York City: see New York, city. New York City City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S. , to serve as its new financial relations and corporate communications advisor for United States investors. The Investor Relations Group will strive to increase investor awareness of DRAXIS Health Inc. within the U.S. market by individually and personally introducing the company and its management to pre-qualified fund managers. In the future, U.S. investor inquiries relating to DRAXIS should be directed to The Investor Relations Group, New York, N.Y., Telephone: 212.825.3210 or Fax: 212.825.3229. In commenting on the new relationship Dr. Martin Barkin, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of DRAXIS, said, "We are working with The Investor Relations Group because it is the right time to raise our profile within the U.S. investing community. IRG knows this community well and will implement a proactive investor relations program that is designed to broaden our existing shareholder base as well as communicate timely information to current stockholders. This appointment is consistent with our recent move to report financial results in U.S. dollars and under U.S. GAAP GAAP See: Generally Accepted Accounting Principles GAAP See generally accepted accounting principles (GAAP). ." About DRAXIS Health Inc. DRAXIS Health Inc. is a diversified specialty pharmaceutical company with operations in three niche markets: radiopharmaceuticals (DRAXIMAGE Inc.), contract manufacturing (DRAXIS Pharma Inc.), and pharmaceutical sales and marketing (DRAXIS Pharmaceutica Inc). This news release contains certain forward-looking statements that involve risk and uncertainties, which may cause actual results to differ materially from the statements made. Such factors include, but are not limited to, changing market conditions, clinical trial results, the establishment of new corporate alliances, the impact of competitive products and pricing, the timely development, regulatory approval and market acceptance of the Company's products, and other risks detailed from time-to-time in the Company's filings with the U.S. Securities and Exchange Commission and Canadian securities authorities. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion